Gene Upshaw Memorial Tahoe Forest Cancer Center Physician Shares Findings at ATA Meeting
Medical Oncologist and Hematologist, Thomas J Semrad, MD, MAS, FACP, of the Gene Upshaw Memorial Tahoe Forest Cancer Center, recently presented his findings at the 87th Annual Meeting of the American Thyroid Association in Victoria, BC. Dr. Semrad is a nationally recognized researcher in cancer treatment and a principal investigator on multiple leading edge clinical trials.
Dr. Semrad and colleagues from UC Davis shared the important results of their study to further understanding and treatment of thyroid cancer. The title of their study is “Survival After Tracheolaryngeal Surgery for Anaplastic/Undifferentiated, Insular and Squamous Cell Thyroid Cancer.”
Over 1,200 thyroid clinicians, investigators and healthcare professionals from around the world attended the conference to hear the latest clinical and basic science research on thyroid disease. The American Thyroid Association is the leading organization focused on thyroid biology and the prevention and treatment of thyroid disorders through excellence and innovation in research, clinical care, education, and public health.
About Gene Upshaw Memorial Tahoe Forest Cancer Center
A service of Tahoe Forest Health System, located in Truckee, California, the Gene Upshaw Memorial Tahoe Forest Cancer Center’s mission is to provide the highest quality cancer treatment and care. An affiliate of UC Davis Comprehensive Cancer Center, and Commission of Cancer accredited, the Gene Upshaw Memorial Tahoe Forest Cancer Center strives to offer the most appropriate and current cancer diagnostic and therapeutic modalities in an honest, supportive, respectful and compassionate manner. For more information, visit tahoecancercenter.com.
